Parallel Advisors’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-8
| Closed | – | – | 3723 |
|
|
2025
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 3712 |
|
|
2024
Q4 | $1 | Hold |
8
| – | – | ﹤0.01% | 3494 |
|
|
2024
Q3 | $2 | Hold |
8
| – | – | ﹤0.01% | 3377 |
|
|
2024
Q2 | $4 | Hold |
8
| – | – | ﹤0.01% | 3287 |
|
|
2024
Q1 | $8 | Hold |
8
| – | – | ﹤0.01% | 3256 |
|
|
2023
Q4 | $5 | Hold |
8
| – | – | ﹤0.01% | 3281 |
|
|
2023
Q3 | $8 | Hold |
8
| – | – | ﹤0.01% | 3325 |
|
|
2023
Q2 | $11 | Hold |
8
| – | – | ﹤0.01% | 3330 |
|
|
2023
Q1 | $13 | Hold |
8
| – | – | ﹤0.01% | 3385 |
|
|
2022
Q4 | $12 | Hold |
8
| – | – | ﹤0.01% | 3310 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 3564 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 3420 |
|
|
2022
Q1 | $0 | Hold |
8
| – | – | ﹤0.01% | 3333 |
|
|
2021
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 3343 |
|
|
2021
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 3268 |
|
|
2021
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 3080 |
|
|
2021
Q1 | $0 | Sell |
8
-1
| -11% | – | ﹤0.01% | 2915 |
|
|
2020
Q4 | $0 | Hold |
9
| – | – | ﹤0.01% | 2742 |
|
|
2020
Q3 | $0 | Hold |
9
| – | – | ﹤0.01% | 2694 |
|
|
2020
Q2 | $0 | Hold |
9
| – | – | ﹤0.01% | 2766 |
|
|
2020
Q1 | $0 | Hold |
9
| – | – | ﹤0.01% | 2702 |
|
|
2019
Q4 | $0 | Sell |
9
-1
| -10% | – | ﹤0.01% | 2520 |
|
|
2019
Q3 | $0 | Buy |
10
+9
| +900% | – | ﹤0.01% | 2518 |
|
|
2019
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 2457 |
|
|
2019
Q1 | $0 | Hold |
1
| – | – | ﹤0.01% | 2423 |
|
|
2018
Q4 | $0 | Buy |
+1
| New | – | ﹤0.01% | 2338 |
|